REnAL denervatIon by ultraSound Transcatheter Emission The REALISE trial is a single-arm, open-label, prospective, post market evaluation to be conducted on twenty (20) eligible patients with a twelve month follow-up period.

• Pays France
• Organes Aucun
• Spécialités Aucune